GIRARDIS, Massimo
 Distribuzione geografica
Continente #
EU - Europa 31.167
NA - Nord America 22.833
AS - Asia 3.731
SA - Sud America 86
OC - Oceania 64
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 32
Totale 57.958
Nazione #
US - Stati Uniti d'America 22.641
IT - Italia 20.722
GB - Regno Unito 5.181
CN - Cina 1.350
SE - Svezia 1.220
DE - Germania 985
HK - Hong Kong 824
FR - Francia 806
UA - Ucraina 695
SG - Singapore 601
FI - Finlandia 463
TR - Turchia 383
BG - Bulgaria 319
CA - Canada 181
ID - Indonesia 151
IN - India 111
RU - Federazione Russa 93
IE - Irlanda 87
CH - Svizzera 68
IR - Iran 67
LT - Lituania 67
NL - Olanda 66
AU - Australia 56
PL - Polonia 53
VN - Vietnam 51
ES - Italia 47
CZ - Repubblica Ceca 43
BE - Belgio 41
RO - Romania 41
KR - Corea 36
JP - Giappone 32
SI - Slovenia 32
BR - Brasile 31
DK - Danimarca 30
EU - Europa 28
MY - Malesia 25
GR - Grecia 20
LB - Libano 18
NO - Norvegia 18
HU - Ungheria 15
CO - Colombia 14
CL - Cile 10
EG - Egitto 10
PH - Filippine 10
AR - Argentina 9
PK - Pakistan 9
SA - Arabia Saudita 9
TN - Tunisia 9
EC - Ecuador 8
NZ - Nuova Zelanda 8
SM - San Marino 8
AE - Emirati Arabi Uniti 7
HR - Croazia 7
PT - Portogallo 7
AT - Austria 6
BO - Bolivia 6
IQ - Iraq 6
RS - Serbia 6
SD - Sudan 6
IL - Israele 5
MD - Moldavia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BD - Bangladesh 4
BY - Bielorussia 4
BZ - Belize 4
KE - Kenya 4
MX - Messico 4
PE - Perù 4
EE - Estonia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LY - Libia 3
OM - Oman 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TW - Taiwan 3
AZ - Azerbaigian 2
ET - Etiopia 2
GE - Georgia 2
JO - Giordania 2
MK - Macedonia 2
MN - Mongolia 2
PA - Panama 2
RW - Ruanda 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
UY - Uruguay 2
VE - Venezuela 2
ZA - Sudafrica 2
AL - Albania 1
CD - Congo 1
GA - Gabon 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
Totale 57.952
Città #
Southend 4.526
Fairfield 3.285
Woodbridge 2.064
Chandler 1.944
Ashburn 1.779
Houston 1.606
Jacksonville 1.422
Seattle 1.183
Cambridge 1.046
Dearborn 1.034
Wilmington 1.020
Milan 998
Nyköping 956
Ann Arbor 942
Rome 857
Hong Kong 807
Bologna 559
Modena 557
Beijing 494
San Diego 413
Singapore 383
Princeton 378
Sofia 311
Torino 310
Florence 286
Eugene 249
New York 246
Turin 242
Helsinki 229
Catania 196
Izmir 195
Redwood City 184
London 177
Padova 154
Naples 149
Palermo 144
Jakarta 142
Verona 136
Genova 134
Castelnuovo Rangone 125
Boardman 111
Parma 109
Napoli 107
Shanghai 107
Venezia 107
Reggio Nell'emilia 100
Pisa 96
Bari 94
Genoa 94
Dallas 85
Des Moines 85
Dublin 78
Trento 72
Bremen 70
Toronto 69
Brescia 63
Trieste 63
Bolzano 59
Monza 59
Norwalk 59
Piemonte 54
Udine 52
Reggio Emilia 51
Bergamo 50
Oggiono 45
Pavia 45
Dong Ket 43
Falls Church 43
Mountain View 42
Munich 42
Cagliari 41
Rio Saliceto 41
Hefei 40
Messina 40
North York 40
Vicenza 39
Rimini 38
Ferrara 34
Grafing 34
Kilburn 33
Alba 32
Jesi 32
Paris 32
Prato 32
Fremont 31
Kunming 31
Nanjing 31
Brussels 30
Chicago 29
Guangzhou 29
Piacenza 29
Brno 28
Dolo 28
Phoenix 28
Treviso 28
Venice 28
Ravenna 27
Chiswick 25
Malo 25
Perugia 25
Totale 34.976
Nome #
RICERCA DI MARCATORI PER LA DIAGNOSI DI INFEZIONE FUNGINA INVASIVAE (IFI) MEDIANTE APPROCCIO DIAGNOSTICO COMBINATO 14.970
EPIDEMIA DA INFEZIONE DI BURKHOLDERIA CEPACIA IN TERAPIA INTENSIVA: SORVEGLIANZA E CONTROLLO 3.564
Acute renal failure and renal replacement therapy in the postoperative period of orthotopic liver transplant patients versus nonelective abdominal surgery patients 713
Hospital staff education on severe sepsis/septic shock and hospital mortality: an original hypothesis 653
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit 648
Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness 642
Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit: The Oxygen-ICU Randomized Clinical Trial 628
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 368
A Position Paper on IgM-Enriched Intravenous Immunoglobulin Adjunctive Therapy in Severe Acute Bacterial Infections: The TO-PIRO SCORE Proposal 367
Oxygen in the critically ill: friend or foe? 302
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 265
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 257
Randomized, multicenter trial of lateral Trendelenburg versus semirecumbent body position for the prevention of ventilator-associated pneumonia 256
Handling and processing of blood specimens from patients with Covid-19 for safe studies on cell phenotype and cytokine storm 253
Wernicke's encephalopathy in a malnourished surgical patient: a difficult diagnosis 243
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 240
Purpura Fulminans and Septic Shock due to Capnocytophaga Canimorsus after Dog Bite: A Case Report and Review of the Literature 238
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 235
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 229
A challenging case of pregnancy with placenta accreta and very rare irregular antibodies versus Cromer blood group system: a case report 221
The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study) 214
A new device for ultrasound-guided peripheral venous access 212
Comment on [A modified goal-directed protocol improves clinical outcome in intensive care unit patients with septic shock patients: a randomized controlled trial.] 207
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia 207
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 206
PSP/reg: a new stone in sepsis biomarkers? 205
A Janus role for MerTK in the outcome of septic shock 205
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 199
Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. 197
Anestesia e disordini vasculo-polmonari nel paziente epatopatico: iter diagnostico e ruolo dello screening precoce 197
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 196
Impact of Pre-Analytical Time on the Recovery of Pathogens from Blood Cultures: Results from a Large Retrospective Survey 195
Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay 193
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 185
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 185
Effectiveness of sepsis bundle application in cirrhotic patients with septic shock: A single-center experience 184
Incidence and clinical outcomes of ventilator-associated pneumonia in liver transplant and non-liver transplant surgical patients. 182
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 177
Early alterations of B cells in patients with septic shock: another piece in the complex puzzle of the immune response in sepsis 176
Effect of performance improvement programs on compliance with sepsis bundles and mortality: A systematic review and meta-analysis of observational studies 175
Successful liver transplantation in a patient with splanchnic vein thrombosis and pulmonary embolism due to polycythemia vera with Jak2v617f mutation and heparin-induced thrombocytopenia. 174
The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections 171
World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections 170
Immune System Dysfunction and Multidrug-resistant Bacteria in Critically Ill Patients: Inflammasones and Future Perspectives 170
A one-year prospective study of refractory status epilepticus in Modena, Italy 169
The aPC treatment improves microcirculation in severe sepsis/septic shock syndrome 168
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia 168
Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial 166
Use of activated protein C in liver transplantation patients with septic shock. 165
Hemostasis in acute liver and kidney failure: nothing is as it seems 165
Early inspiratory effort assessment by esophageal manometry early predicts noninvasive ventilation outcome in de novo respiratory failure: a pilot study. 165
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 165
Effects of short-term hyperoxia on erythropoietin levels and microcirculation in critically Ill patients: a prospective observational pilot study 165
Two-stage liver transplantation: an effective procedure in urgent conditions. 163
Characteristics and outcome predictors of patients involved in an outbreak of Burkholderia cepacia complex 163
Albumin replacement in patients with severe sepsis or septic shock 163
CYTOREDUCTIVE SURGERY AND HIPEC IN A 14 YEARS OLD PATIENT WITH PERITONEAL RECURRENCE OF ADENOCARCINOMA OF THE RIGHT COLON 161
Dexmedetomidine for agitated delirium in intensive care unit intubated patients 161
Hypokalemia in Patients with COVID-19 161
JLB: a flexible and effective device in critical patients. Review of clinical cases 160
Endotoxin activity levels as a prediction tool for risk of deterioration in patients with sepsis not admitted to the intensive care unit: a pilot observational study 159
Levosimendan in cardiac failure after subarachnoid hemorrhage. 159
Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August-September 2009. 159
Adjunctive therapy with vitamin c and thiamine in patients treated with steroids for refractory septic shock: A propensity matched before-after, case-control study 159
Ostruzione tardiva delle vie aeree da ematoma retrofaringeo secondario a trauma cranico lieve 158
Trends in ventilator-associated pneumonia: Impact of a ventilator care bundle in an Italian tertiary care hospital intensive care unit 157
Bronchoalveolar lavage (BAL) and supplementation with exogenous surfactant in adults with acute respiratory distress syndrome (ARDS) 156
Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP) 156
Peri-operative respiratory failure in a cirrhotic patient: a misleading diagnosis. 156
Massive bleeding: Are we doing our best? 155
Never Give Up: lesson learned from a severe COVID-19 patient. 154
Comment on: "Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock" by Formica et al. 153
Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock 152
Posttransplant cerebral hemorrhage in a patient with familial amyloidotic polyneuropathy 152
The prognostic importance of chronic end-stage diseases in geriatric patients admitted to 163 Italian ICUs 152
Assessment of cardiac output from noninvasive determination of arterial pressure profile in subjects at rest. 151
Aggressive versus conservative initiation of antibiotics 150
Perioperative red blood cell transfusion and outcome in stable patients after elective major vascular surgery. 150
Mortality in Patients With Septic Shock by Multidrug Resistant Bacteria: Risk Factors and Impact of Sepsis Treatments 149
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 149
Increased Plasma Levels of Mitochondrial DNA and Normal Inflammasome Gene Expression in Monocytes Characterize Patients With Septic Shock Due to Multidrug Resistant Bacteria 149
Case report of a patient who survived after cardiac arrest and cardiogenic shock by anaphylactic reaction to gadolinium during magnetic resonance imaging 148
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 147
Muscle perfusion and oxygen consumption by near-infrared spectroscopy in septic-shock and non-septic-shock patients 146
Pain management after small bowel/multivisceral transplantation 146
Recombinant activated factor VII in critical bleeding after orthotopic liver transplantation. 146
Loss of self-regulation in interstitial fluid dynamics of septic patients, and oedema development patterns 146
Intra-abdominal hypertension in nonelective surgery: A preliminary report 145
Energetics of best performances in middle-distance running. 145
Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection 143
Arterial hyperoxia and mortality in critically ill patients: a systematic review and meta-analysis 143
Delayed upper airway obstruction following a retropharyngeal haematoma after minor head trauma. 141
Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study 141
Intracerebral haemorrhage: an often neglected medical emergency. 140
Levosimendan in a case of severe peri-myocarditis associated with influenza A/H1N1 virus. 140
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 140
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study 138
Abdominal compartment syndrome and fluid replacement: a dog that bites its own tail? 138
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 138
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial 137
Totale 38.445
Categoria #
all - tutte 202.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 202.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.015 0 0 727 824 1.236 1.456 1.584 964 986 787 864 587
2020/202110.434 906 610 998 914 1.285 806 909 1.022 599 995 764 626
2021/20227.795 596 778 686 462 313 404 512 486 856 550 1.058 1.094
2022/20238.797 953 864 675 722 869 992 390 828 1.016 339 585 564
2023/20246.790 461 553 541 724 1.052 526 567 785 222 249 361 749
2024/2025951 569 379 3 0 0 0 0 0 0 0 0 0
Totale 58.693